XTX Topco’s ProMIS Neurosciences PMN Stock Holding History

XTX Topco’s Portfolio PMN Stock Details PMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,707	Closed	-$28.8K	–	3681
2025 Q3	$28.8K	Buy	+2,707	New	+$37.5K	﹤0.01%	2269

Other funds holding PMN

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DEM

Disciplined Equity Management Neptune Beach, Florida $226M AUM 27.21% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

XTX Topco's PMN Position: Q4 2025 in Review

XTX Topco sold out of ProMIS Neurosciences (PMN) in Q4 2025, closing a stake of 2,707 shares — an estimated $28.8K sold.

XTX Topco first reported a position in PMN in Q3 2025 and held it in 1 quarter. The position peaked at $28.8K in Q3 2025. 9 funds tracked by Wall St. Rank hold PMN as of Q4 2025.

XTX Topco reported no remaining ProMIS Neurosciences position as of Q4 2025 after selling out during the quarter.
XTX Topco sold 2,707 ProMIS Neurosciences shares in Q4 2025, an estimated $28.8K.
XTX Topco first reported a position in ProMIS Neurosciences in Q3 2025 and held it in 1 quarter.
XTX Topco's ProMIS Neurosciences position peaked at $28.8K in Q3 2025.
9 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.